Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

Share Price is delayed by 15 minutes
Get Live Data
115.00    3.50 (3.14%)
Bid:
112.00
Ask:
118.00
Spread: 6.00 (5.357%)
Market Cap: £69.19m
IGP Live PriceLast checked at - London Stock Exchange

Intraday Intercede Share Chart

Trading Statement

31 Mar 2006 07:02

Intercede Group PLC31 March 2006 31 MARCH 2006 INTERCEDE GROUP PLC ("Intercede" or "the Company") Trading Update for the Full Year to 31 March 2006 Intercede today provides an update on trading at the end of its financial yearended 31 March 2006. Intercede is pleased to report significant progress over the past year incontinuing to strengthen its position in the identity and smart card managementmarket. This market is relatively new, but is expected to grow rapidly as aresult of the increasing need for digital identities for employees, citizens andindividuals. It is likely that every citizen, and especially every employee, inthe US and EU will have a digital identity within the next 3 to 5 years. We seethis becoming a global trend within the next 10 years. During the financial year, we have added RSA Security and VeriSign to ourgrowing OEM partner list. SafeNet has also become an active OEM partnerfollowing its acquisition of Datakey, a long term Intercede partner. RSASecurity, SafeNet and Verisign are the top three corporate IT security solutionscompanies in the world. It is an outstanding achievement for Intercede to havepenetrated the main supply chains which service its target market. The fact thatlarge, global entities such as these are choosing topartner with Intercede is a major endorsement for its MyID identity and smartcard management software. The US Federal Government's, Homeland Security Presidential Decision-12, knownas HSPD-12, is creating a major new and specific market opportunity forIntercede's MyID technology. This directive stated that smart card identitybadges will be issued to all US Federal Government employees and contractorsstarting in October 2006. HSPD-12 is also accelerating the use of smart cards inthe rest of the US market. Through its partner network, Intercede is in anexcellent position to exploit this rapid growth as the US becomes the largestsingle market for smart card technology. It is too early to say with certaintywhen the contracts to procure the necessary technology will be awarded.However, Intercede has developed strong links with a range of partners who willbe actively involved in this process and is therefore well placed to exploitthis market opportunity at its earliest stages. The outturn for the current year is now expected to result in revenues that willbe slightly lower than previously expected and a small loss is expected to beincurred. The year end cash balance will, however, close ahead of target. Thisis primarily the result of the accounting treatment of a non-refundable paymentof £0.3m for OEM licences. Although the payment was received in January 2006, itwill nevertheless be taken as revenue in the financial year ending 31 March2007. Intercede expects to announce its full year results towards the end of May 2006. About Intercede Intercede Group plc is a leading developer and supplier of smart card andidentity management software listed on the London Stock Exchange (IGP LN)(IGP.L). The Group's MyID software manages the secure registration, issuance andlifecycle of digital identities for a wide range of uses. This requires theintegration of multiple technologies and products from many different vendors,including smart cards, biometrics, digital certificates and Open Platformapplets. Intercede's customers cover a range of industries and include Athena SmartcardSolutions, Department of Transport Ireland, Fujitsu, Getronics PinkRoccade,GemPlus, Lloyds TSB, National Health Service (NHS), Metropolitan Police,Oberthur Card Systems, RSA Security, Royal Bank of Scotland, SafeNet, Siemens,Thales, Ubizen, VeriSign and various US and UK Government agencies anddepartments. For more information, visit www.intercede.com Intercede and MyID are registered trademarks or trademarks in the UK and/orother countries. ENQUIRIES Intercede Group plc Tel. +44 (0)1455 558111Richard Parris, Chairman & Chief ExecutiveAndrew Walker, Finance Director Pelham Public Relations Tel. +44 (0)20 7743 6679Archie Berens This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSNotice of Results & Investor Presentation
25th Oct 20247:00 amRNSShare Buyback Programme
11th Oct 20248:38 amRNSDirector/PDMR Shareholding
8th Oct 20247:00 amRNSTrading Update
1st Oct 20247:00 amRNSNotification of Trading Update and H1 FY25 Results
30th Sep 20247:00 amRNSContract Orders and Renewals
25th Sep 202412:51 pmRNSResult of AGM
20th Sep 202411:45 amRNSDirector/PDMR Shareholding
18th Sep 20247:00 amRNSContract Orders and Renewals
2nd Sep 20247:00 amRNSContract Orders and Subscription Renewals
30th Aug 20247:00 amRNSNotice of AGM and Publication of Annual Report
4th Jul 20243:58 pmRNSIssue of Equity & Total Voting Rights
28th Jun 20243:49 pmRNSIssue of Equity & Total Voting Rights
26th Jun 20247:00 amRNSPartnership with Carahsoft Technology Corp
19th Jun 20246:25 pmRNSHolding(s) in Company
18th Jun 20249:17 amRNSHolding(s) in Company
18th Jun 20247:15 amRNSDirector/PDMR Shareholding and Issue of Equity
18th Jun 20247:00 amRNSFinal Results
5th Jun 20247:00 amRNSNotice of Results & Investor Presentation
16th May 202412:00 pmRNSCapital Markets Day - Agenda Update
14th May 20246:17 pmRNSShare Incentive Scheme
26th Apr 202410:02 amRNSShare Incentive Scheme
23rd Apr 20247:00 amRNSCapital Markets Day
8th Apr 20247:00 amRNSTrading Update
2nd Apr 20247:00 amRNSContract and Subscription Renewals
25th Mar 20243:38 pmRNSHolding(s) in Company
25th Mar 20243:35 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSNew Orders and Trading Update
21st Mar 20247:00 amRNSNew Product Announcement: Launch of MyID MFA v5
6th Feb 20247:00 amRNSDirector/PDMR Shareholding
29th Jan 20247:00 amRNSNew Orders
18th Jan 20249:55 amRNSDirector/PDMR Shareholding
3rd Jan 20247:00 amRNSMajor New Contract Win
7th Dec 20237:00 amRNSUpdate on Major New Contract Win
5th Dec 202312:30 pmRNSMajor New Contract with Large US Federal Agency
22nd Nov 20237:00 amRNSDirector/PDMR Shareholding
21st Nov 20237:01 amRNSNew Contract and Renewal Orders
21st Nov 20237:00 amRNSHalf-year Report
7th Nov 20237:00 amRNSContract and Renewals Orders
25th Oct 20234:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.